OSI Pharmaceuticals, Inc. (OSIP)

CAPS Rating:

A mid-cap biotechnology company committed to building a scientifically strong and financially successful top tier biopharmaceutical organization that discovers, develops and commercializes innovative molecular targeted therapies.